Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression
NCT07925762, Not applicable, Recruiting, University of Sao Paulo
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression | ClinicalTrials.gov |
| NCT number | NCT07925762 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 104 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University of Sao Paulo | ClinicalTrials.gov |
| Conditions | Postpartum Depression, Depression, Postpartum | ClinicalTrials.gov |
| Interventions | Smartphone-Assisted Single-Session Psychotherapy Intervention | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Depressive symptoms (clinician-rated) | Week 4 (post-treatment, T3) | Total score on the Quick Inventory of Depressive Symptomatology, Clinician-Rated (QIDS-C16), administered by masked assessors. Range 0-27; higher scores indicate more severe depression. | ClinicalTrials.gov |
| Secondary | Depressive symptoms (self-report) | Week 4 (T3) and week 8 (T4) | Total score on the Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR16). Range 0-27; higher scores indicate more severe depression. | ClinicalTrials.gov |
| Secondary | Anxiety Symptoms | Week 4 (T3) and week 8 (T4) | Total score on the Generalized Anxiety Disorder 7-item scale (GAD-7). Range 0-21; higher scores indicate more severe anxiety. | ClinicalTrials.gov |
| Secondary | Sleep problems | Week 4 (T3) and week 8 (T4) | Global score on the Pittsburgh Sleep Quality Index (PSQI). Range 0-21; higher scores indicate worse sleep quality. | ClinicalTrials.gov |
| Secondary | Parental distress | Week 4 (T3) and week 8 (T4) | Parental Distress subscale of the Parenting Stress Index Short Form (PSI-SF). Range 12-60; higher scores indicate more stress. | ClinicalTrials.gov |
| Secondary | Parent-child dysfunctional interaction | Week 4 (T3) and week 8 (T4) | Parent-Child Dysfunctional Interaction subscale of the PSI-SF. Range 12-60; higher scores indicate more stress. | ClinicalTrials.gov |
| Secondary | Parenting stress | Week 4 (T3) and week 8 (T4) | Total score of the PSI-SF. Range 36-180; higher scores indicate more stress. | ClinicalTrials.gov |
| Secondary | Functional impairment | Week 4 (T3) and week 8 (T4) | Total score on the Sheehan Disability Scale (SDS), covering work/school, social life and family life. Range 0-30; higher scores indicate more impairment. | ClinicalTrials.gov |
| Secondary | Change in depression severity and functional impairment relative to baseline | Week 4 (T3) | Clinical Global Impression - Improvement (CGI-I), rated by masked assessors relative to baseline (T1). Range 1 (very much improved) to 7 (very much worse). | ClinicalTrials.gov |
| Other | Postnatal depressive symptoms (EPDS) | Week 4 (T3), week 8 (T4) | Total score on the Edinburgh Postnatal Depression Scale. Range 0-30; higher scores indicate more symptoms. Used for comparison with the PPD literature. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)